ApprovalTrail

Drug · DIN 02413388

JUBLIA

Yes: authorized and sold in Canada

Authorized, and the company reports that it sells it in Canada.

Status Marketed since January 21, 2020; first marketed July 21, 2014.
Drug Identification Number (DIN)
02413388
Company (DIN owner)
Bausch Health, Canada Inc.Laval, Quebec, Canada
Schedule
Prescription
Dosage form
Solution
Route
Topical
Therapeutic class (ATC)
Efinaconazole D01AC19
Class
Human
Record last updated
April 2, 2026

Active ingredients

As listed in the Drug Product Database.

IngredientStrengthPer
EFINACONAZOLE10 %W/W

Notices of Compliance

Health Canada approvals that name this DIN.